Hepatitis C (English Wikipedia)

Wilkins T, Malcolm JK, Raina D, Schade RR (June 2010). "Hepatitis C: diagnosis and treatment" (PDF). American Family Physician. 81 (11): 1351–1357. PMID 20521755. Archived (PDF) from the original on 2013-05-21.
Lam NC, Gotsch PB, Langan RC (November 2010). "Caring for pregnant women and newborns with hepatitis B or C" (PDF). American Family Physician. 82 (10): 1225–9. PMID 21121533. Archived (PDF) from the original on 2013-05-21.

archive.org

Ryan KJ, Ray CG, eds. (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. pp. 551–52. ISBN 978-0-8385-8529-0.
Little JW, Falace DA, Miller C, Rhodus NL (2013). Dental Management of the Medically Compromised Patient. p. 151. ISBN 978-0323080286.
Marx J (2010). Rosen's emergency medicine: concepts and clinical practice (7th ed.). Philadelphia, PA: Mosby/Elsevier. p. 1154. ISBN 978-0-323-05472-0.
Holmberg S (2011-05-12). Brunette GW, Kozarsky PE, Magill AJ, Shlim DR, Whatley AD (eds.). CDC Health Information for International Travel 2012. New York: Oxford University Press. p. 231. ISBN 978-0-19-976901-8.

bbc.co.uk

news.bbc.co.uk

"Spanish Hep C anaesthetist jailed". BBC. 15 May 2007. Archived from the original on 23 October 2007.

bbc.com

Gallagher J (2020-10-05). "Hepatitis C discovery wins the Nobel Prize". BBC News. Retrieved 2020-10-05.

books.google.com

Shors T (2011). Understanding viruses (2nd ed.). Burlington, MA: Jones & Bartlett Learning. p. 535. ISBN 978-0-7637-8553-6. Archived from the original on 2016-05-15.
Chronic Hepatitis C Virus Advances in Treatment, Promise for the Future. Springer Verlag. 2011. p. 14. ISBN 978-1-4614-1191-8. Archived from the original on 2016-06-17.
Kanwal F, Bacon BR (2011). "Does Treatment Alter the Natural History of Chronic HCV?". In Schiffman ML (ed.). Chronic Hepatitis C Virus Advances in Treatment, Promise for the Future. Springer Verlag. pp. 103–04. ISBN 978-1-4614-1191-8.
Pockros P (2011). Novel and Combination Therapies for Hepatitis C Virus, An Issue of Clinics in Liver Disease. Elsevier Health Sciences. p. 47. ISBN 978-1-4557-7198-1. Archived from the original on 2016-05-21.
Day RA, Paul P, Williams B (2009). Brunner & Suddarth's textbook of Canadian medical-surgical nursing (Canadian 2nd ed.). Philadelphia, PA: Lippincott Williams & Wilkins. p. 1237. ISBN 978-0-7817-9989-8. Archived from the original on 2016-04-25.
Sanders M (2011). Mosby's Paramedic Textbook. Jones & Bartlett Publishers. p. 839. ISBN 978-0-323-07275-5. Archived from the original on 2016-05-11.
Helms RA, Quan DJ, eds. (2006). Textbook of Therapeutics: Drug and Disease Management (8th ed.). Philadelphia, PA [u.a.]: Lippincott Williams & Wilkins. p. 1340. ISBN 978-0-7817-5734-8. Archived from the original on 5 December 2015. Retrieved 7 November 2014.
Blatt LM, Tong M (2004). Colacino JM, Heinz BA (eds.). Hepatitis prevention and treatment. Basel: Birkhäuser. p. 32. ISBN 978-3-7643-5956-0. Archived from the original on 2016-06-24.
Boyer JL (2001). Liver cirrhosis and its development: proceedings of the Falk Symposium 115. Springer. pp. 344. ISBN 978-0-7923-8760-2.
Thomas H, Lemon S, Zuckerman A, eds. (2008). Viral Hepatitis (3rd ed.). Oxford: John Wiley & Sons. p. 532. ISBN 978-1-4051-4388-2. Archived from the original on 2016-06-17.

cdc.gov

"Q&A for Health Professionals". Viral Hepatitis. Centers for Disease Control and Prevention. Retrieved 28 September 2020.
"Hepatitis C" (PDF). Centers for Disease Control and Prevention (CDC). Archived (PDF) from the original on 5 January 2012. Retrieved 2 January 2012.
"Hepatitis C FAQs for Health Professionals". Centers for Disease Control and Prevention (CDC). Archived from the original on 4 January 2012. Retrieved 2 January 2012.
Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, et al. (August 2012). "Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965" (PDF). MMWR. Recommendations and Reports. 61 (RR-4): 1–32. PMID 22895429.
"Testing Recommendations for Hepatitis C Virus Infection – HCV – Division of Viral Hepatitis". U.S. Centers for Disease Control and Prevention (CDC). 12 June 2019. Retrieved 11 January 2020.
"People Born 1945–1965 (Baby Boomers) – Populations and Settings – Division of Viral Hepatitis". U.S. Centers for Disease Control and Prevention (CDC). 26 July 2019. Archived from the original on 22 October 2019. Retrieved 11 January 2020.
CDC (2021-06-14). "Hepatitis C | CDC". Centers for Disease Control and Prevention. Retrieved 2023-03-27.
"Hepatitis C Questions and Answers for Health Professionals". www.cdc.gov. 2 July 2019. Retrieved 23 July 2019.
"U.S. 2014 Surveillance Data for Viral Hepatitis, Statistics & Surveillance, Division of Viral Hepatitis". CDC. Archived from the original on 2016-08-08. Retrieved 2016-08-04.
Table 4.5. "Number and rate of deaths with hepatitis C listed as a cause of death, by demographic characteristic and year – United States, 2004–2008". Viral Hepatitis on the CDC web site. Centers for Disease Control and Prevention, Atlanta, GA. Archived from the original on 9 March 2014. Retrieved 28 July 2013.{{cite web}}: CS1 maint: numeric names: authors list (link)
"Hepatitis C Kills More Americans than Any Other Infectious Disease". Centers for Disease Control and Prevention. May 4, 2016. Archived from the original on 9 August 2016. Retrieved 3 August 2016.

cocaine.org

Laureen Veevers (1 October 2006). "'Shared banknote' health warning to cocaine users". The Observer. Retrieved 2008-07-26.

contagionlive.com

"Biden Administration, Others Working Towards Eliminating Hepatitis C". 13 March 2023.

doi.org

Maheshwari A, Thuluvath PJ (February 2010). "Management of acute hepatitis C". Clinics in Liver Disease. 14 (1): 169–76, x. doi:10.1016/j.cld.2009.11.007. PMID 20123448.
Rosen HR (June 2011). "Clinical practice. Chronic hepatitis C infection". The New England Journal of Medicine. 364 (25): 2429–38. doi:10.1056/NEJMcp1006613. PMID 21696309. S2CID 19755395.
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. (March 2020). "Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement". JAMA. 323 (10): 970–975. doi:10.1001/jama.2020.1123. PMID 32119076.
Webster DP, Klenerman P, Dusheiko GM (March 2015). "Hepatitis C". Lancet. 385 (9973): 1124–35. doi:10.1016/S0140-6736(14)62401-6. PMC 4878852. PMID 25687730.
Zelenev A, Li J, Mazhnaya A, Basu S, Altice FL (February 2018). "Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study". The Lancet. Infectious Diseases. 18 (2): 215–224. doi:10.1016/S1473-3099(17)30676-X. PMC 5860640. PMID 29153265.
Kim A (September 2016). "Hepatitis C Virus". Annals of Internal Medicine (Review). 165 (5): ITC33–ITC48. doi:10.7326/AITC201609060. PMID 27595226. S2CID 95756.
Houghton M (November 2009). "The long and winding road leading to the identification of the hepatitis C virus". Journal of Hepatology. 51 (5): 939–48. doi:10.1016/j.jhep.2009.08.004. PMID 19781804.
Rao A, Rule JA, Cerro-Chiang G, Stravitz RT, McGuire BM, Lee G, et al. (January 2023). "Role of Hepatitis C Infection in Acute Liver Injury/Acute Liver Failure in North America". Digestive Diseases and Sciences. 68 (1): 304–311. doi:10.1007/s10620-022-07524-6. PMC 9094131. PMID 35546205.
Forton DM, Allsop JM, Cox IJ, Hamilton G, Wesnes K, Thomas HC, Taylor-Robinson SD (October 2005). "A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection". AIDS. 19 (Suppl 3): S53-63. doi:10.1097/01.aids.0000192071.72948.77. PMID 16251829.
El-Zayadi AR (July 2008). "Hepatic steatosis: a benign disease or a silent killer". World Journal of Gastroenterology. 14 (26): 4120–6. doi:10.3748/wjg.14.4120. PMC 2725370. PMID 18636654.
Paradis V, Bedossa P (December 2008). "Definition and natural history of metabolic steatosis: histology and cellular aspects". Diabetes & Metabolism. 34 (6 Pt 2): 638–42. doi:10.1016/S1262-3636(08)74598-1. PMID 19195624.
Alter MJ (May 2007). "Epidemiology of hepatitis C virus infection". World Journal of Gastroenterology. 13 (17): 2436–41. doi:10.3748/wjg.v13.i17.2436. PMC 4146761. PMID 17552026.
Mueller S, Millonig G, Seitz HK (July 2009). "Alcoholic liver disease and hepatitis C: a frequently underestimated combination". World Journal of Gastroenterology. 15 (28): 3462–71. doi:10.3748/wjg.15.3462. PMC 2715970. PMID 19630099.
Fattovich G, Stroffolini T, Zagni I, Donato F (November 2004). "Hepatocellular carcinoma in cirrhosis: incidence and risk factors". Gastroenterology. 127 (5 Suppl 1): S35-50. doi:10.1053/j.gastro.2004.09.014. PMID 15508101.
Ozaras R, Tahan V (April 2009). "Acute hepatitis C: prevention and treatment". Expert Review of Anti-Infective Therapy. 7 (3): 351–61. doi:10.1586/eri.09.8. PMID 19344247. S2CID 25574917.
Zaltron S, Spinetti A, Biasi L, Baiguera C, Castelli F (2012). "Chronic HCV infection: epidemiological and clinical relevance". BMC Infectious Diseases. 12 (Suppl 2): S2. doi:10.1186/1471-2334-12-S2-S2. PMC 3495628. PMID 23173556.
Dammacco F, Sansonno D (September 2013). "Therapy for hepatitis C virus-related cryoglobulinemic vasculitis". The New England Journal of Medicine. 369 (11): 1035–45. doi:10.1056/NEJMra1208642. PMID 24024840. S2CID 205116488.
Iannuzzella F, Vaglio A, Garini G (May 2010). "Management of hepatitis C virus-related mixed cryoglobulinemia". The American Journal of Medicine. 123 (5): 400–8. doi:10.1016/j.amjmed.2009.09.038. PMID 20399313.
Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (January 2007). "Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach". Digestive and Liver Disease. 39 (1): 2–17. doi:10.1016/j.dld.2006.06.008. PMID 16884964.
Ko HM, Hernandez-Prera JC, Zhu H, Dikman SH, Sidhu HK, Ward SC, Thung SN (2012). "Morphologic features of extrahepatic manifestations of hepatitis C virus infection". Clinical & Developmental Immunology. 2012: 740138. doi:10.1155/2012/740138. PMC 3420144. PMID 22919404.
Dammacco F, Sansonno D, Piccoli C, Racanelli V, D'Amore FP, Lauletta G (2000). "The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy". Seminars in Liver Disease. 20 (2): 143–57. doi:10.1055/s-2000-9613. PMID 10946420. S2CID 260318352.
Lee MR, Shumack S (November 2005). "Prurigo nodularis: a review". The Australasian Journal of Dermatology. 46 (4): 211–18, quiz 219–20. doi:10.1111/j.1440-0960.2005.00187.x. PMID 16197418. S2CID 30087432.
Matsumori A (2006). "Role of hepatitis C virus in cardiomyopathies.". Ernst Schering Research Foundation Workshop. Vol. 55. pp. 99–120. doi:10.1007/3-540-30822-9_7. ISBN 978-3-540-23971-0. PMID 16329660.
Moretti R, Giuffrè M, Merli N, Caruso P, Di Bella S, Tiribelli C, Crocè LS (November 2021). "Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders". Brain Sciences. 11 (12): 1569. doi:10.3390/brainsci11121569. PMC 8699483. PMID 34942871.
Monaco S, Ferrari S, Gajofatto A, Zanusso G, Mariotto S (2012). "HCV-related nervous system disorders". Clinical & Developmental Immunology. 2012: 236148. doi:10.1155/2012/236148. PMC 3414089. PMID 22899946.
Xu JH, Fu JJ, Wang XL, Zhu JY, Ye XH, Chen SD (July 2013). "Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies". World Journal of Gastroenterology. 19 (26): 4234–41. doi:10.3748/wjg.v19.i26.4234. PMC 3710428. PMID 23864789.
Lodi G, Porter SR, Scully C (July 1998). "Hepatitis C virus infection: Review and implications for the dentist". Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 86 (1): 8–22. CiteSeerX 10.1.1.852.7880. doi:10.1016/S1079-2104(98)90143-3. PMID 9690239.
Carrozzo M, Gandolfo S (2003-03-01). "Oral diseases possibly associated with hepatitis C virus". Critical Reviews in Oral Biology and Medicine. 14 (2): 115–27. doi:10.1177/154411130301400205. PMID 12764074.
Sugden PB, Cameron B, Bull R, White PA, Lloyd AR (September 2012). "Occult infection with hepatitis C virus: friend or foe?". Immunology and Cell Biology. 90 (8): 763–73. doi:10.1038/icb.2012.20. PMID 22546735. S2CID 23845868.
Carreño V (November 2006). "Occult hepatitis C virus infection: a new form of hepatitis C". World Journal of Gastroenterology. 12 (43): 6922–5. doi:10.3748/wjg.12.6922. PMC 4087333. PMID 17109511.
Carreño García V, Nebreda JB, Aguilar IC, Quiroga Estévez JA (March 2011). "[Occult hepatitis C virus infection]". Enfermedades Infecciosas y Microbiologia Clinica. 29 (Suppl 3): 14–9. doi:10.1016/S0213-005X(11)70022-2. PMID 21458706.
Pham TN, Coffin CS, Michalak TI (April 2010). "Occult hepatitis C virus infection: what does it mean?". Liver International. 30 (4): 502–11. doi:10.1111/j.1478-3231.2009.02193.x. PMID 20070513. S2CID 205651069.
Carreño V, Bartolomé J, Castillo I, Quiroga JA (June 2012). "New perspectives in occult hepatitis C virus infection". World Journal of Gastroenterology. 18 (23): 2887–94. doi:10.3748/wjg.v18.i23.2887. PMC 3380315. PMID 22736911.
Carreño V, Bartolomé J, Castillo I, Quiroga JA (May–June 2008). "Occult hepatitis B virus and hepatitis C virus infections". Reviews in Medical Virology. 18 (3): 139–57. doi:10.1002/rmv.569. PMID 18265423. S2CID 12331754.
Scott JD, Gretch DR (February 2007). "Molecular diagnostics of hepatitis C virus infection: a systematic review". JAMA. 297 (7): 724–732. doi:10.1001/jama.297.7.724. PMID 17312292.
Robinson JL (July 2008). "Vertical transmission of the hepatitis C virus: Current knowledge and issues". Paediatrics & Child Health. 13 (6): 529–541. doi:10.1093/pch/13.6.529. PMC 2532905. PMID 19436425.
Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M (February 2012). "An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region". Liver International. 32 (2): 339–45. doi:10.1111/j.1478-3231.2011.02684.x. PMID 22142261. S2CID 23271017.
Lerat H, Hollinger FB (January 2004). "Hepatitis C virus (HCV) occult infection or occult HCV RNA detection?". The Journal of Infectious Diseases. 189 (1): 3–6. doi:10.1086/380203. PMID 14702146.
Zignego AL, Giannini C, Gragnani L, Piluso A, Fognani E (August 2012). "Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact". Journal of Translational Medicine. 10 (1): 158. doi:10.1186/1479-5876-10-158. PMC 3441205. PMID 22863056.
Hagan LM, Schinazi RF (February 2013). "Best strategies for global HCV eradication". Liver International. 33 (s1): 68–79. doi:10.1111/liv.12063. PMC 4110680. PMID 23286849.
Pondé RA (February 2011). "Hidden hazards of HCV transmission". Medical Microbiology and Immunology. 200 (1): 7–11. doi:10.1007/s00430-010-0159-9. PMID 20461405. S2CID 664199.
Jafari S, Copes R, Baharlou S, Etminan M, Buxton J (November 2010). "Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis". International Journal of Infectious Diseases. 14 (11): e928-40. doi:10.1016/j.ijid.2010.03.019. PMID 20678951.
Xia X, Luo J, Bai J, Yu R (October 2008). "Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis". Public Health. 122 (10): 990–1003. doi:10.1016/j.puhe.2008.01.014. PMID 18486955.
Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L (August 2011). "Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews". Lancet. 378 (9791): 571–83. doi:10.1016/S0140-6736(11)61097-0. PMC 3285467. PMID 21802134.
Imperial JC (June 2010). "Chronic hepatitis C in the state prison system: insights into the problems and possible solutions". Expert Review of Gastroenterology & Hepatology. 4 (3): 355–64. doi:10.1586/egh.10.26. PMID 20528122. S2CID 7931472.
Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, Monarca R (April 2008). "Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis". Journal of Epidemiology and Community Health. 62 (4): 305–13. doi:10.1136/jech.2006.051599. PMID 18339822. S2CID 206989111.
Moyer VA (September 2013). "Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement". Annals of Internal Medicine. 159 (5): 349–57. doi:10.7326/0003-4819-159-5-201309030-00672. PMID 23798026. S2CID 8563203.
Lock G, Dirscherl M, Obermeier F, Gelbmann CM, Hellerbrand C, Knöll A, et al. (September 2006). "Hepatitis C - contamination of toothbrushes: myth or reality?". Journal of Viral Hepatitis. 13 (9): 571–3. doi:10.1111/j.1365-2893.2006.00735.x. PMID 16907842. S2CID 24264376.
Wong T, Lee SS (February 2006). "Hepatitis C: a review for primary care physicians". CMAJ. 174 (5): 649–59. doi:10.1503/cmaj.1030034. PMC 1389829. PMID 16505462.
Mast EE (2004). "Mother-to-Infant Hepatitis C Virus Transmission and Breastfeeding". Protecting Infants through Human Milk. Advances in Experimental Medicine and Biology. Vol. 554. pp. 211–16. doi:10.1007/978-1-4757-4242-8_18. ISBN 978-1-4419-3461-1. PMID 15384578.
Tohme RA, Holmberg SD (October 2010). "Is sexual contact a major mode of hepatitis C virus transmission?". Hepatology. 52 (4): 1497–505. doi:10.1002/hep.23808. PMID 20635398. S2CID 5592006.
Westbrook RH, Dusheiko G (November 2014). "Natural history of hepatitis C". Journal of Hepatology. 61 (1 Suppl): S58-68. doi:10.1016/j.jhep.2014.07.012. PMID 25443346.
Patel K, Muir AJ, McHutchison JG (April 2006). "Diagnosis and treatment of chronic hepatitis C infection". BMJ. 332 (7548): 1013–7. doi:10.1136/bmj.332.7548.1013. PMC 1450048. PMID 16644828.
Shivkumar S, Peeling R, Jafari Y, Joseph L, Pant Pai N (October 2012). "Accuracy of rapid and point-of-care screening tests for hepatitis C: a systematic review and meta-analysis". Annals of Internal Medicine. 157 (8): 558–66. doi:10.7326/0003-4819-157-8-201210160-00006. PMID 23070489. S2CID 5650682.
Senadhi V (July 2011). "A paradigm shift in the outpatient approach to liver function tests". Southern Medical Journal. 104 (7): 521–5. doi:10.1097/SMJ.0b013e31821e8ff5. PMID 21886053. S2CID 26462106.
Shah H, Bilodeau M, Burak KW, Cooper C, Klein M, Ramji A, et al. (June 2018). "The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver". CMAJ. 190 (22): E677–E687. doi:10.1503/cmaj.170453. PMC 5988519. PMID 29866893.
Hagan H, Pouget ER, Des Jarlais DC (July 2011). "A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs". The Journal of Infectious Diseases. 204 (1): 74–83. doi:10.1093/infdis/jir196. PMC 3105033. PMID 21628661.
AASLD/IDSA HCV Guidance Panel (September 2015). "Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus". Hepatology. 62 (3): 932–54. doi:10.1002/hep.27950. PMID 26111063.
Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, et al. (September 2017). "Direct-acting antivirals for chronic hepatitis C". The Cochrane Database of Systematic Reviews. 2017 (9): CD012143. doi:10.1002/14651858.CD012143.pub3. PMC 6484376. PMID 28922704.
Liang TJ, Ghany MG (May 2013). "Current and future therapies for hepatitis C virus infection". The New England Journal of Medicine. 368 (20): 1907–17. doi:10.1056/NEJMra1213651. PMC 3893124. PMID 23675659.
Mücke MM, Backus LI, Mücke VT, Coppola N, Preda CM, Yeh ML, et al. (March 2018). "Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis". The Lancet. Gastroenterology & Hepatology. 3 (3): 172–180. doi:10.1016/S2468-1253(18)30002-5. PMID 29371017.
Ciria R, Pleguezuelo M, Khorsandi SE, Davila D, Suddle A, Vilca-Melendez H, et al. (May 2013). "Strategies to reduce hepatitis C virus recurrence after liver transplantation". World Journal of Hepatology. 5 (5): 237–50. doi:10.4254/wjh.v5.i5.237. PMC 3664282. PMID 23717735.
Coilly A, Roche B, Samuel D (February 2013). "Current management and perspectives for HCV recurrence after liver transplantation". Liver International. 33 (Suppl 1): 56–62. doi:10.1111/liv.12062. PMID 23286847. S2CID 23601091.
Gurusamy KS, Tsochatzis E, Toon CD, Xirouchakis E, Burroughs AK, Davidson BR (December 2013). "Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus". The Cochrane Database of Systematic Reviews. 2014 (12): CD006803. doi:10.1002/14651858.CD006803.pub4. PMC 8930021. PMID 24307460.
Liu J, Manheimer E, Tsutani K, Gluud C (March 2003). "Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials". The American Journal of Gastroenterology. 98 (3): 538–44. doi:10.1111/j.1572-0241.2003.07298.x. PMID 12650784. S2CID 20014583.
Rambaldi A, Jacobs BP, Gluud C (October 2007). "Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases". The Cochrane Database of Systematic Reviews. 2009 (4): CD003620. doi:10.1002/14651858.CD003620.pub3. PMC 8724782. PMID 17943794.
Morgan RL, Baack B, Smith BD, Yartel A, Pitasi M, Falck-Ytter Y (March 2013). "Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies". Annals of Internal Medicine. 158 (5 Pt 1): 329–37. doi:10.7326/0003-4819-158-5-201303050-00005. PMID 23460056. S2CID 15553488.
Fung J, Lai CL, Hung I, Young J, Cheng C, Wong D, Yuen MF (September 2008). "Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin". The Journal of Infectious Diseases. 198 (6): 808–12. doi:10.1086/591252. PMID 18657036.
Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST (April 2013). "Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence". Hepatology. 57 (4): 1333–42. doi:10.1002/hep.26141. PMID 23172780. S2CID 16265266.
Yu ML, Chuang WL (March 2009). "Treatment of chronic hepatitis C in Asia: when East meets West". Journal of Gastroenterology and Hepatology. 24 (3): 336–45. doi:10.1111/j.1440-1746.2009.05789.x. PMID 19335784. S2CID 27333980.
Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F (March 2013). "The burden of liver disease in Europe: a review of available epidemiological data". Journal of Hepatology. 58 (3): 593–608. doi:10.1016/j.jhep.2012.12.005. PMID 23419824.
Lombardi A, Mondelli MU (March 2019). "Hepatitis C: Is eradication possible?". Liver International. 39 (3): 416–426. doi:10.1111/liv.14011. hdl:2434/870308. PMID 30472772.
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (April 1989). "Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome" (PDF). Science. 244 (4902): 359–62. Bibcode:1989Sci...244..359C. CiteSeerX 10.1.1.469.3592. doi:10.1126/science.2523562. PMID 2523562.
Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. (April 1989). "An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis". Science. 244 (4902): 362–4. Bibcode:1989Sci...244..362K. doi:10.1126/science.2496467. PMID 2496467.
Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, et al. (July 2005). "Production of infectious hepatitis C virus in tissue culture from a cloned viral genome". Nature Medicine. 11 (7): 791–796. doi:10.1038/nm1268. PMC 2918402. PMID 15951748.
Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, et al. (September 2017). "Direct-acting antivirals for chronic hepatitis C". The Cochrane Database of Systematic Reviews. 2017 (9): CD012143. doi:10.1002/14651858.CD012143.pub3. PMC 6484376. PMID 28922704.
Koretz RL, Lin KW, Ioannidis JP, Lenzer J (January 2015). "Is widespread screening for hepatitis C justified?". BMJ. 350: g7809. doi:10.1136/bmj.g7809. PMID 25587052. S2CID 36816304.
Ledford H (19 October 2020). "The unsung heroes of the Nobel-winning hepatitis C discovery". Nature. 586 (7830): 485. Bibcode:2020Natur.586..485L. doi:10.1038/d41586-020-02932-y. PMID 33082542. S2CID 224822368. Retrieved 20 October 2020.
Wong JB (2006). "Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies". PharmacoEconomics. 24 (7): 661–72. doi:10.2165/00019053-200624070-00005. PMID 16802842. S2CID 6713508.
El Khoury AC, Klimack WK, Wallace C, Razavi H (March 2012). "Economic burden of hepatitis C-associated diseases in the United States". Journal of Viral Hepatitis. 19 (3): 153–60. doi:10.1111/j.1365-2893.2011.01563.x. PMID 22329369. S2CID 27409621.
Arshad M, El-Kamary SS, Jhaveri R (April 2011). "Hepatitis C virus infection during pregnancy and the newborn period--are they opportunities for treatment?". Journal of Viral Hepatitis. 18 (4): 229–36. doi:10.1111/j.1365-2893.2010.01413.x. PMID 21392169. S2CID 35515919.
Hunt CM, Carson KL, Sharara AI (May 1997). "Hepatitis C in pregnancy". Obstetrics and Gynecology. 89 (5 Pt 2): 883–90. doi:10.1016/S0029-7844(97)81434-2. PMID 9166361. S2CID 23182340.
Thomas SL, Newell ML, Peckham CS, Ades AE, Hall AJ (February 1998). "A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection". International Journal of Epidemiology. 27 (1): 108–17. doi:10.1093/ije/27.1.108. PMID 9563703.
Fischler B (June 2007). "Hepatitis C virus infection". Seminars in Fetal & Neonatal Medicine. 12 (3): 168–73. CiteSeerX 10.1.1.852.7880. doi:10.1016/j.siny.2007.01.008. PMID 17320495.
Indolfi G, Resti M (May 2009). "Perinatal transmission of hepatitis C virus infection". Journal of Medical Virology. 81 (5): 836–43. doi:10.1002/jmv.21437. PMID 19319981. S2CID 21207996.
González-Peralta RP (November 1997). "Hepatitis C virus infection in pediatric patients". Clinics in Liver Disease. 1 (3): 691–705, ix. doi:10.1016/s1089-3261(05)70329-9. PMID 15560066.
Suskind DL, Rosenthal P (February 2004). "Chronic viral hepatitis". Adolescent Medicine Clinics. 15 (1): 145–58, x–xi. doi:10.1016/j.admecli.2003.11.001. PMID 15272262.
Einav S, Koziel MJ (June 2002). "Immunopathogenesis of hepatitis C virus in the immunosuppressed host". Transplant Infectious Disease. 4 (2): 85–92. doi:10.1034/j.1399-3062.2002.t01-2-02001.x. PMID 12220245. S2CID 27843061.
Iorio A, Marchesini E, Awad T, Gluud LL (January 2010). "Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus". The Cochrane Database of Systematic Reviews (1): CD004888. doi:10.1002/14651858.CD004888.pub2. PMID 20091566.
Ahn J, Flamm SL (August 2011). "Hepatitis C therapy: other players in the game". Clinics in Liver Disease. 15 (3): 641–56. doi:10.1016/j.cld.2011.05.008. PMID 21867942.
Vermehren J, Sarrazin C (February 2011). "New HCV therapies on the horizon". Clinical Microbiology and Infection. 17 (2): 122–34. doi:10.1111/j.1469-0691.2010.03430.x. PMID 21087349.
Abdelwahab KS, Ahmed Said ZN (January 2016). "Status of hepatitis C virus vaccination: Recent update". World Journal of Gastroenterology. 22 (2): 862–73. doi:10.3748/wjg.v22.i2.862. PMC 4716084. PMID 26811632.
Feld JJ, Jacobson IM, Hézode C, Asselah T, Ruane PJ, Gruener N, et al. (December 2015). "Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection". The New England Journal of Medicine. 373 (27): 2599–607. doi:10.1056/NEJMoa1512610. hdl:10722/226358. PMID 26571066.
Gurusamy KS, Tsochatzis E, Toon CD, Davidson BR, Burroughs AK (December 2013). "Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation". The Cochrane Database of Systematic Reviews. 2013 (12): CD006573. doi:10.1002/14651858.CD006573.pub3. PMC 6599865. PMID 24297303.
Sandmann L, Ploss A (January 2013). "Barriers of hepatitis C virus interspecies transmission". Virology. 435 (1): 70–80. doi:10.1016/j.virol.2012.09.044. PMC 3523278. PMID 23217617.

egypttoday.com

"Hepatitis C prevalence in Egypt drops from 7% to 2% thanks to Sisi's initiative". EgyptToday. 2021-02-06. Retrieved 2021-03-06.

espacenet.com

worldwide.espacenet.com

EP patent 0318216, Houghton M, Choo QL, Kuo G, "NANBV diagnostics", issued 1989-05-31, assigned to Chiron

eurosurveillance.org

Eurosurveillance editorial team (July 2011). "World Hepatitis Day 2011" (PDF). Euro Surveillance. 16 (30). PMID 21813077. Archived (PDF) from the original on 2011-11-25.

fda.gov

"FDA approves Vosevi for Hepatitis C". U.S. Food and Drug Administration (FDA) (Press release). 18 July 2017. Archived from the original on 23 July 2017. Retrieved 27 July 2017.

findlaw.com

caselaw.findlaw.com

Wilken (20 February 1998). "United States Court of Appeals for the Federal Circuit". United States Court of Appeals for the Federal Circuit. Archived from the original on 19 November 2009.

handle.net

hdl.handle.net

Lombardi A, Mondelli MU (March 2019). "Hepatitis C: Is eradication possible?". Liver International. 39 (3): 416–426. doi:10.1111/liv.14011. hdl:2434/870308. PMID 30472772.
Feld JJ, Jacobson IM, Hézode C, Asselah T, Ruane PJ, Gruener N, et al. (December 2015). "Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection". The New England Journal of Medicine. 373 (27): 2599–607. doi:10.1056/NEJMoa1512610. hdl:10722/226358. PMID 26571066.

harvard.edu

ui.adsabs.harvard.edu

Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (April 1989). "Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome" (PDF). Science. 244 (4902): 359–62. Bibcode:1989Sci...244..359C. CiteSeerX 10.1.1.469.3592. doi:10.1126/science.2523562. PMID 2523562.
Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. (April 1989). "An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis". Science. 244 (4902): 362–4. Bibcode:1989Sci...244..362K. doi:10.1126/science.2496467. PMID 2496467.
Ledford H (19 October 2020). "The unsung heroes of the Nobel-winning hepatitis C discovery". Nature. 586 (7830): 485. Bibcode:2020Natur.586..485L. doi:10.1038/d41586-020-02932-y. PMID 33082542. S2CID 224822368. Retrieved 20 October 2020.

hcvguidelines.org

"HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C" (PDF). 12 April 2017. Archived from the original (PDF) on 2017-07-10. Retrieved 28 July 2017.
"Treatment: Naive Genotype 1a Without Cirrhosis". HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. American Association for the Study of Liver Diseases. Retrieved 26 April 2017 – via www.hcvguidelines.org.
"Treatment: Naive Genotype 1a With Compensated Cirrhosis". HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. American Association for the Study of Liver Diseases. Retrieved 26 April 2017 – via www.hcvguidelines.org.
"Treatment: Naive Genotype 1b Without Cirrhosis". HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. American Association for the Study of Liver Diseases. Retrieved 26 April 2017 – via www.hcvguidelines.org.
"Treatment: Naive Genotype 1b With Compensated Cirrhosis". HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. American Association for the Study of Liver Diseases. Retrieved 26 April 2017 – via www.hcvguidelines.org.
"Treatment; Naive Genotype 2 Without Cirrhosis". HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. American Association for the Study of Liver Diseases. Retrieved 26 April 2017 – via www.hcvguidelines.org.
"Treatment – Naive Genotype 2 With Compensated Cirrhosis". HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. American Association for the Study of Liver Diseases. Retrieved 26 April 2017 – via www.hcvguidelines.org.
"Treatment: Naive Genotype 3 Without Cirrhosis". HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. American Association for the Study of Liver Diseases. Retrieved 26 April 2017 – via www.hcvguidelines.org.
"Treatment: Naive Genotype 3 With Compensated Cirrhosis". HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. American Association for the Study of Liver Diseases. Retrieved 26 April 2017 – via www.hcvguidelines.org.
"Treatment: Naive Genotype 4 Without Cirrhosis". HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. American Association for the Study of Liver Diseases. Retrieved 26 April 2017 – via www.hcvguidelines.org.
"Treatment: Naive Genotype 4 With Compensated Cirrhosis". HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. American Association for the Study of Liver Diseases. Retrieved 26 April 2017 – via www.hcvguidelines.org.
"Treatment: Naive Genotype 5 or 6". HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. American Association for the Study of Liver Diseases. Retrieved 26 April 2017 – via www.hcvguidelines.org.

hsj.co.uk

"Legal action firm among winners for largest medicines procurement". Health Service Journal. 30 April 2019. Retrieved 9 June 2019.
Blackledge C (19 March 2015). "Commissioning supplement: Health inequalities tell a tale of data neglect". Health Service Journal. Archived from the original on 28 July 2015.

journal-of-hepatology.eu

Houghton M (November 2009). "The long and winding road leading to the identification of the hepatitis C virus". Journal of Hepatology. 51 (5): 939–48. doi:10.1016/j.jhep.2009.08.004. PMID 19781804.

medlineplus.gov

"Hepatitis MedlinePlus". U.S. National Library of Medicine. Retrieved 2020-06-19.

microblogology.com

Cramer L (1 September 2011). "Fomites, fomites, fomites!". Microblogology. Archived from the original on 23 September 2020. Retrieved 8 March 2019.

nature.com

Ledford H (19 October 2020). "The unsung heroes of the Nobel-winning hepatitis C discovery". Nature. 586 (7830): 485. Bibcode:2020Natur.586..485L. doi:10.1038/d41586-020-02932-y. PMID 33082542. S2CID 224822368. Retrieved 20 October 2020.

nhs.uk

"Hepatitis C". NHS UK. 27 October 2021.

nih.gov

pubmed.ncbi.nlm.nih.gov

Maheshwari A, Thuluvath PJ (February 2010). "Management of acute hepatitis C". Clinics in Liver Disease. 14 (1): 169–76, x. doi:10.1016/j.cld.2009.11.007. PMID 20123448.
Rosen HR (June 2011). "Clinical practice. Chronic hepatitis C infection". The New England Journal of Medicine. 364 (25): 2429–38. doi:10.1056/NEJMcp1006613. PMID 21696309. S2CID 19755395.
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. (March 2020). "Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement". JAMA. 323 (10): 970–975. doi:10.1001/jama.2020.1123. PMID 32119076.
Webster DP, Klenerman P, Dusheiko GM (March 2015). "Hepatitis C". Lancet. 385 (9973): 1124–35. doi:10.1016/S0140-6736(14)62401-6. PMC 4878852. PMID 25687730.
Zelenev A, Li J, Mazhnaya A, Basu S, Altice FL (February 2018). "Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study". The Lancet. Infectious Diseases. 18 (2): 215–224. doi:10.1016/S1473-3099(17)30676-X. PMC 5860640. PMID 29153265.
Kim A (September 2016). "Hepatitis C Virus". Annals of Internal Medicine (Review). 165 (5): ITC33–ITC48. doi:10.7326/AITC201609060. PMID 27595226. S2CID 95756.
Houghton M (November 2009). "The long and winding road leading to the identification of the hepatitis C virus". Journal of Hepatology. 51 (5): 939–48. doi:10.1016/j.jhep.2009.08.004. PMID 19781804.
Wilkins T, Malcolm JK, Raina D, Schade RR (June 2010). "Hepatitis C: diagnosis and treatment" (PDF). American Family Physician. 81 (11): 1351–1357. PMID 20521755. Archived (PDF) from the original on 2013-05-21.
Rao A, Rule JA, Cerro-Chiang G, Stravitz RT, McGuire BM, Lee G, et al. (January 2023). "Role of Hepatitis C Infection in Acute Liver Injury/Acute Liver Failure in North America". Digestive Diseases and Sciences. 68 (1): 304–311. doi:10.1007/s10620-022-07524-6. PMC 9094131. PMID 35546205.
Forton DM, Allsop JM, Cox IJ, Hamilton G, Wesnes K, Thomas HC, Taylor-Robinson SD (October 2005). "A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection". AIDS. 19 (Suppl 3): S53-63. doi:10.1097/01.aids.0000192071.72948.77. PMID 16251829.
El-Zayadi AR (July 2008). "Hepatic steatosis: a benign disease or a silent killer". World Journal of Gastroenterology. 14 (26): 4120–6. doi:10.3748/wjg.14.4120. PMC 2725370. PMID 18636654.
Paradis V, Bedossa P (December 2008). "Definition and natural history of metabolic steatosis: histology and cellular aspects". Diabetes & Metabolism. 34 (6 Pt 2): 638–42. doi:10.1016/S1262-3636(08)74598-1. PMID 19195624.
Alter MJ (May 2007). "Epidemiology of hepatitis C virus infection". World Journal of Gastroenterology. 13 (17): 2436–41. doi:10.3748/wjg.v13.i17.2436. PMC 4146761. PMID 17552026.
Mueller S, Millonig G, Seitz HK (July 2009). "Alcoholic liver disease and hepatitis C: a frequently underestimated combination". World Journal of Gastroenterology. 15 (28): 3462–71. doi:10.3748/wjg.15.3462. PMC 2715970. PMID 19630099.
Fattovich G, Stroffolini T, Zagni I, Donato F (November 2004). "Hepatocellular carcinoma in cirrhosis: incidence and risk factors". Gastroenterology. 127 (5 Suppl 1): S35-50. doi:10.1053/j.gastro.2004.09.014. PMID 15508101.
Ozaras R, Tahan V (April 2009). "Acute hepatitis C: prevention and treatment". Expert Review of Anti-Infective Therapy. 7 (3): 351–61. doi:10.1586/eri.09.8. PMID 19344247. S2CID 25574917.
Zaltron S, Spinetti A, Biasi L, Baiguera C, Castelli F (2012). "Chronic HCV infection: epidemiological and clinical relevance". BMC Infectious Diseases. 12 (Suppl 2): S2. doi:10.1186/1471-2334-12-S2-S2. PMC 3495628. PMID 23173556.
Dammacco F, Sansonno D (September 2013). "Therapy for hepatitis C virus-related cryoglobulinemic vasculitis". The New England Journal of Medicine. 369 (11): 1035–45. doi:10.1056/NEJMra1208642. PMID 24024840. S2CID 205116488.
Iannuzzella F, Vaglio A, Garini G (May 2010). "Management of hepatitis C virus-related mixed cryoglobulinemia". The American Journal of Medicine. 123 (5): 400–8. doi:10.1016/j.amjmed.2009.09.038. PMID 20399313.
Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (January 2007). "Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach". Digestive and Liver Disease. 39 (1): 2–17. doi:10.1016/j.dld.2006.06.008. PMID 16884964.
Ko HM, Hernandez-Prera JC, Zhu H, Dikman SH, Sidhu HK, Ward SC, Thung SN (2012). "Morphologic features of extrahepatic manifestations of hepatitis C virus infection". Clinical & Developmental Immunology. 2012: 740138. doi:10.1155/2012/740138. PMC 3420144. PMID 22919404.
Dammacco F, Sansonno D, Piccoli C, Racanelli V, D'Amore FP, Lauletta G (2000). "The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy". Seminars in Liver Disease. 20 (2): 143–57. doi:10.1055/s-2000-9613. PMID 10946420. S2CID 260318352.
Lee MR, Shumack S (November 2005). "Prurigo nodularis: a review". The Australasian Journal of Dermatology. 46 (4): 211–18, quiz 219–20. doi:10.1111/j.1440-0960.2005.00187.x. PMID 16197418. S2CID 30087432.
Matsumori A (2006). "Role of hepatitis C virus in cardiomyopathies.". Ernst Schering Research Foundation Workshop. Vol. 55. pp. 99–120. doi:10.1007/3-540-30822-9_7. ISBN 978-3-540-23971-0. PMID 16329660.
Moretti R, Giuffrè M, Merli N, Caruso P, Di Bella S, Tiribelli C, Crocè LS (November 2021). "Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders". Brain Sciences. 11 (12): 1569. doi:10.3390/brainsci11121569. PMC 8699483. PMID 34942871.
Monaco S, Ferrari S, Gajofatto A, Zanusso G, Mariotto S (2012). "HCV-related nervous system disorders". Clinical & Developmental Immunology. 2012: 236148. doi:10.1155/2012/236148. PMC 3414089. PMID 22899946.
Xu JH, Fu JJ, Wang XL, Zhu JY, Ye XH, Chen SD (July 2013). "Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies". World Journal of Gastroenterology. 19 (26): 4234–41. doi:10.3748/wjg.v19.i26.4234. PMC 3710428. PMID 23864789.
Lodi G, Porter SR, Scully C (July 1998). "Hepatitis C virus infection: Review and implications for the dentist". Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 86 (1): 8–22. CiteSeerX 10.1.1.852.7880. doi:10.1016/S1079-2104(98)90143-3. PMID 9690239.
Carrozzo M, Gandolfo S (2003-03-01). "Oral diseases possibly associated with hepatitis C virus". Critical Reviews in Oral Biology and Medicine. 14 (2): 115–27. doi:10.1177/154411130301400205. PMID 12764074.
Sugden PB, Cameron B, Bull R, White PA, Lloyd AR (September 2012). "Occult infection with hepatitis C virus: friend or foe?". Immunology and Cell Biology. 90 (8): 763–73. doi:10.1038/icb.2012.20. PMID 22546735. S2CID 23845868.
Carreño V (November 2006). "Occult hepatitis C virus infection: a new form of hepatitis C". World Journal of Gastroenterology. 12 (43): 6922–5. doi:10.3748/wjg.12.6922. PMC 4087333. PMID 17109511.
Carreño García V, Nebreda JB, Aguilar IC, Quiroga Estévez JA (March 2011). "[Occult hepatitis C virus infection]". Enfermedades Infecciosas y Microbiologia Clinica. 29 (Suppl 3): 14–9. doi:10.1016/S0213-005X(11)70022-2. PMID 21458706.
Pham TN, Coffin CS, Michalak TI (April 2010). "Occult hepatitis C virus infection: what does it mean?". Liver International. 30 (4): 502–11. doi:10.1111/j.1478-3231.2009.02193.x. PMID 20070513. S2CID 205651069.
Carreño V, Bartolomé J, Castillo I, Quiroga JA (June 2012). "New perspectives in occult hepatitis C virus infection". World Journal of Gastroenterology. 18 (23): 2887–94. doi:10.3748/wjg.v18.i23.2887. PMC 3380315. PMID 22736911.
Carreño V, Bartolomé J, Castillo I, Quiroga JA (May–June 2008). "Occult hepatitis B virus and hepatitis C virus infections". Reviews in Medical Virology. 18 (3): 139–57. doi:10.1002/rmv.569. PMID 18265423. S2CID 12331754.
Scott JD, Gretch DR (February 2007). "Molecular diagnostics of hepatitis C virus infection: a systematic review". JAMA. 297 (7): 724–732. doi:10.1001/jama.297.7.724. PMID 17312292.
Robinson JL (July 2008). "Vertical transmission of the hepatitis C virus: Current knowledge and issues". Paediatrics & Child Health. 13 (6): 529–541. doi:10.1093/pch/13.6.529. PMC 2532905. PMID 19436425.
Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M (February 2012). "An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region". Liver International. 32 (2): 339–45. doi:10.1111/j.1478-3231.2011.02684.x. PMID 22142261. S2CID 23271017.
Lerat H, Hollinger FB (January 2004). "Hepatitis C virus (HCV) occult infection or occult HCV RNA detection?". The Journal of Infectious Diseases. 189 (1): 3–6. doi:10.1086/380203. PMID 14702146.
Zignego AL, Giannini C, Gragnani L, Piluso A, Fognani E (August 2012). "Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact". Journal of Translational Medicine. 10 (1): 158. doi:10.1186/1479-5876-10-158. PMC 3441205. PMID 22863056.
Hagan LM, Schinazi RF (February 2013). "Best strategies for global HCV eradication". Liver International. 33 (s1): 68–79. doi:10.1111/liv.12063. PMC 4110680. PMID 23286849.
Pondé RA (February 2011). "Hidden hazards of HCV transmission". Medical Microbiology and Immunology. 200 (1): 7–11. doi:10.1007/s00430-010-0159-9. PMID 20461405. S2CID 664199.
Jafari S, Copes R, Baharlou S, Etminan M, Buxton J (November 2010). "Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis". International Journal of Infectious Diseases. 14 (11): e928-40. doi:10.1016/j.ijid.2010.03.019. PMID 20678951.
Xia X, Luo J, Bai J, Yu R (October 2008). "Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis". Public Health. 122 (10): 990–1003. doi:10.1016/j.puhe.2008.01.014. PMID 18486955.
Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L (August 2011). "Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews". Lancet. 378 (9791): 571–83. doi:10.1016/S0140-6736(11)61097-0. PMC 3285467. PMID 21802134.
Imperial JC (June 2010). "Chronic hepatitis C in the state prison system: insights into the problems and possible solutions". Expert Review of Gastroenterology & Hepatology. 4 (3): 355–64. doi:10.1586/egh.10.26. PMID 20528122. S2CID 7931472.
Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, Monarca R (April 2008). "Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis". Journal of Epidemiology and Community Health. 62 (4): 305–13. doi:10.1136/jech.2006.051599. PMID 18339822. S2CID 206989111.
Moyer VA (September 2013). "Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement". Annals of Internal Medicine. 159 (5): 349–57. doi:10.7326/0003-4819-159-5-201309030-00672. PMID 23798026. S2CID 8563203.
Lock G, Dirscherl M, Obermeier F, Gelbmann CM, Hellerbrand C, Knöll A, et al. (September 2006). "Hepatitis C - contamination of toothbrushes: myth or reality?". Journal of Viral Hepatitis. 13 (9): 571–3. doi:10.1111/j.1365-2893.2006.00735.x. PMID 16907842. S2CID 24264376.
Wong T, Lee SS (February 2006). "Hepatitis C: a review for primary care physicians". CMAJ. 174 (5): 649–59. doi:10.1503/cmaj.1030034. PMC 1389829. PMID 16505462.
Lam NC, Gotsch PB, Langan RC (November 2010). "Caring for pregnant women and newborns with hepatitis B or C" (PDF). American Family Physician. 82 (10): 1225–9. PMID 21121533. Archived (PDF) from the original on 2013-05-21.
Mast EE (2004). "Mother-to-Infant Hepatitis C Virus Transmission and Breastfeeding". Protecting Infants through Human Milk. Advances in Experimental Medicine and Biology. Vol. 554. pp. 211–16. doi:10.1007/978-1-4757-4242-8_18. ISBN 978-1-4419-3461-1. PMID 15384578.
Tohme RA, Holmberg SD (October 2010). "Is sexual contact a major mode of hepatitis C virus transmission?". Hepatology. 52 (4): 1497–505. doi:10.1002/hep.23808. PMID 20635398. S2CID 5592006.
Westbrook RH, Dusheiko G (November 2014). "Natural history of hepatitis C". Journal of Hepatology. 61 (1 Suppl): S58-68. doi:10.1016/j.jhep.2014.07.012. PMID 25443346.
Patel K, Muir AJ, McHutchison JG (April 2006). "Diagnosis and treatment of chronic hepatitis C infection". BMJ. 332 (7548): 1013–7. doi:10.1136/bmj.332.7548.1013. PMC 1450048. PMID 16644828.
Shivkumar S, Peeling R, Jafari Y, Joseph L, Pant Pai N (October 2012). "Accuracy of rapid and point-of-care screening tests for hepatitis C: a systematic review and meta-analysis". Annals of Internal Medicine. 157 (8): 558–66. doi:10.7326/0003-4819-157-8-201210160-00006. PMID 23070489. S2CID 5650682.
Senadhi V (July 2011). "A paradigm shift in the outpatient approach to liver function tests". Southern Medical Journal. 104 (7): 521–5. doi:10.1097/SMJ.0b013e31821e8ff5. PMID 21886053. S2CID 26462106.
Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, et al. (August 2012). "Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965" (PDF). MMWR. Recommendations and Reports. 61 (RR-4): 1–32. PMID 22895429.
Shah H, Bilodeau M, Burak KW, Cooper C, Klein M, Ramji A, et al. (June 2018). "The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver". CMAJ. 190 (22): E677–E687. doi:10.1503/cmaj.170453. PMC 5988519. PMID 29866893.
Hagan H, Pouget ER, Des Jarlais DC (July 2011). "A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs". The Journal of Infectious Diseases. 204 (1): 74–83. doi:10.1093/infdis/jir196. PMC 3105033. PMID 21628661.
AASLD/IDSA HCV Guidance Panel (September 2015). "Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus". Hepatology. 62 (3): 932–54. doi:10.1002/hep.27950. PMID 26111063.
Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, et al. (September 2017). "Direct-acting antivirals for chronic hepatitis C". The Cochrane Database of Systematic Reviews. 2017 (9): CD012143. doi:10.1002/14651858.CD012143.pub3. PMC 6484376. PMID 28922704.
Liang TJ, Ghany MG (May 2013). "Current and future therapies for hepatitis C virus infection". The New England Journal of Medicine. 368 (20): 1907–17. doi:10.1056/NEJMra1213651. PMC 3893124. PMID 23675659.
Mücke MM, Backus LI, Mücke VT, Coppola N, Preda CM, Yeh ML, et al. (March 2018). "Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis". The Lancet. Gastroenterology & Hepatology. 3 (3): 172–180. doi:10.1016/S2468-1253(18)30002-5. PMID 29371017.
Ciria R, Pleguezuelo M, Khorsandi SE, Davila D, Suddle A, Vilca-Melendez H, et al. (May 2013). "Strategies to reduce hepatitis C virus recurrence after liver transplantation". World Journal of Hepatology. 5 (5): 237–50. doi:10.4254/wjh.v5.i5.237. PMC 3664282. PMID 23717735.
Coilly A, Roche B, Samuel D (February 2013). "Current management and perspectives for HCV recurrence after liver transplantation". Liver International. 33 (Suppl 1): 56–62. doi:10.1111/liv.12062. PMID 23286847. S2CID 23601091.
Gurusamy KS, Tsochatzis E, Toon CD, Xirouchakis E, Burroughs AK, Davidson BR (December 2013). "Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus". The Cochrane Database of Systematic Reviews. 2014 (12): CD006803. doi:10.1002/14651858.CD006803.pub4. PMC 8930021. PMID 24307460.
Liu J, Manheimer E, Tsutani K, Gluud C (March 2003). "Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials". The American Journal of Gastroenterology. 98 (3): 538–44. doi:10.1111/j.1572-0241.2003.07298.x. PMID 12650784. S2CID 20014583.
Rambaldi A, Jacobs BP, Gluud C (October 2007). "Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases". The Cochrane Database of Systematic Reviews. 2009 (4): CD003620. doi:10.1002/14651858.CD003620.pub3. PMC 8724782. PMID 17943794.
Morgan RL, Baack B, Smith BD, Yartel A, Pitasi M, Falck-Ytter Y (March 2013). "Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies". Annals of Internal Medicine. 158 (5 Pt 1): 329–37. doi:10.7326/0003-4819-158-5-201303050-00005. PMID 23460056. S2CID 15553488.
Fung J, Lai CL, Hung I, Young J, Cheng C, Wong D, Yuen MF (September 2008). "Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin". The Journal of Infectious Diseases. 198 (6): 808–12. doi:10.1086/591252. PMID 18657036.
Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST (April 2013). "Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence". Hepatology. 57 (4): 1333–42. doi:10.1002/hep.26141. PMID 23172780. S2CID 16265266.
Yu ML, Chuang WL (March 2009). "Treatment of chronic hepatitis C in Asia: when East meets West". Journal of Gastroenterology and Hepatology. 24 (3): 336–45. doi:10.1111/j.1440-1746.2009.05789.x. PMID 19335784. S2CID 27333980.
Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F (March 2013). "The burden of liver disease in Europe: a review of available epidemiological data". Journal of Hepatology. 58 (3): 593–608. doi:10.1016/j.jhep.2012.12.005. PMID 23419824.
Lombardi A, Mondelli MU (March 2019). "Hepatitis C: Is eradication possible?". Liver International. 39 (3): 416–426. doi:10.1111/liv.14011. hdl:2434/870308. PMID 30472772.
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (April 1989). "Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome" (PDF). Science. 244 (4902): 359–62. Bibcode:1989Sci...244..359C. CiteSeerX 10.1.1.469.3592. doi:10.1126/science.2523562. PMID 2523562.
Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. (April 1989). "An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis". Science. 244 (4902): 362–4. Bibcode:1989Sci...244..362K. doi:10.1126/science.2496467. PMID 2496467.
Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, et al. (July 2005). "Production of infectious hepatitis C virus in tissue culture from a cloned viral genome". Nature Medicine. 11 (7): 791–796. doi:10.1038/nm1268. PMC 2918402. PMID 15951748.
Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, et al. (September 2017). "Direct-acting antivirals for chronic hepatitis C". The Cochrane Database of Systematic Reviews. 2017 (9): CD012143. doi:10.1002/14651858.CD012143.pub3. PMC 6484376. PMID 28922704.
Koretz RL, Lin KW, Ioannidis JP, Lenzer J (January 2015). "Is widespread screening for hepatitis C justified?". BMJ. 350: g7809. doi:10.1136/bmj.g7809. PMID 25587052. S2CID 36816304.
Ledford H (19 October 2020). "The unsung heroes of the Nobel-winning hepatitis C discovery". Nature. 586 (7830): 485. Bibcode:2020Natur.586..485L. doi:10.1038/d41586-020-02932-y. PMID 33082542. S2CID 224822368. Retrieved 20 October 2020.
Eurosurveillance editorial team (July 2011). "World Hepatitis Day 2011" (PDF). Euro Surveillance. 16 (30). PMID 21813077. Archived (PDF) from the original on 2011-11-25.
Wong JB (2006). "Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies". PharmacoEconomics. 24 (7): 661–72. doi:10.2165/00019053-200624070-00005. PMID 16802842. S2CID 6713508.
El Khoury AC, Klimack WK, Wallace C, Razavi H (March 2012). "Economic burden of hepatitis C-associated diseases in the United States". Journal of Viral Hepatitis. 19 (3): 153–60. doi:10.1111/j.1365-2893.2011.01563.x. PMID 22329369. S2CID 27409621.
Arshad M, El-Kamary SS, Jhaveri R (April 2011). "Hepatitis C virus infection during pregnancy and the newborn period--are they opportunities for treatment?". Journal of Viral Hepatitis. 18 (4): 229–36. doi:10.1111/j.1365-2893.2010.01413.x. PMID 21392169. S2CID 35515919.
Hunt CM, Carson KL, Sharara AI (May 1997). "Hepatitis C in pregnancy". Obstetrics and Gynecology. 89 (5 Pt 2): 883–90. doi:10.1016/S0029-7844(97)81434-2. PMID 9166361. S2CID 23182340.
Thomas SL, Newell ML, Peckham CS, Ades AE, Hall AJ (February 1998). "A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection". International Journal of Epidemiology. 27 (1): 108–17. doi:10.1093/ije/27.1.108. PMID 9563703.
Fischler B (June 2007). "Hepatitis C virus infection". Seminars in Fetal & Neonatal Medicine. 12 (3): 168–73. CiteSeerX 10.1.1.852.7880. doi:10.1016/j.siny.2007.01.008. PMID 17320495.
Indolfi G, Resti M (May 2009). "Perinatal transmission of hepatitis C virus infection". Journal of Medical Virology. 81 (5): 836–43. doi:10.1002/jmv.21437. PMID 19319981. S2CID 21207996.
González-Peralta RP (November 1997). "Hepatitis C virus infection in pediatric patients". Clinics in Liver Disease. 1 (3): 691–705, ix. doi:10.1016/s1089-3261(05)70329-9. PMID 15560066.
Suskind DL, Rosenthal P (February 2004). "Chronic viral hepatitis". Adolescent Medicine Clinics. 15 (1): 145–58, x–xi. doi:10.1016/j.admecli.2003.11.001. PMID 15272262.
Einav S, Koziel MJ (June 2002). "Immunopathogenesis of hepatitis C virus in the immunosuppressed host". Transplant Infectious Disease. 4 (2): 85–92. doi:10.1034/j.1399-3062.2002.t01-2-02001.x. PMID 12220245. S2CID 27843061.
Iorio A, Marchesini E, Awad T, Gluud LL (January 2010). "Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus". The Cochrane Database of Systematic Reviews (1): CD004888. doi:10.1002/14651858.CD004888.pub2. PMID 20091566.
Ahn J, Flamm SL (August 2011). "Hepatitis C therapy: other players in the game". Clinics in Liver Disease. 15 (3): 641–56. doi:10.1016/j.cld.2011.05.008. PMID 21867942.
Vermehren J, Sarrazin C (February 2011). "New HCV therapies on the horizon". Clinical Microbiology and Infection. 17 (2): 122–34. doi:10.1111/j.1469-0691.2010.03430.x. PMID 21087349.
Abdelwahab KS, Ahmed Said ZN (January 2016). "Status of hepatitis C virus vaccination: Recent update". World Journal of Gastroenterology. 22 (2): 862–73. doi:10.3748/wjg.v22.i2.862. PMC 4716084. PMID 26811632.
Feld JJ, Jacobson IM, Hézode C, Asselah T, Ruane PJ, Gruener N, et al. (December 2015). "Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection". The New England Journal of Medicine. 373 (27): 2599–607. doi:10.1056/NEJMoa1512610. hdl:10722/226358. PMID 26571066.
Gurusamy KS, Tsochatzis E, Toon CD, Davidson BR, Burroughs AK (December 2013). "Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation". The Cochrane Database of Systematic Reviews. 2013 (12): CD006573. doi:10.1002/14651858.CD006573.pub3. PMC 6599865. PMID 24297303.
Sandmann L, Ploss A (January 2013). "Barriers of hepatitis C virus interspecies transmission". Virology. 435 (1): 70–80. doi:10.1016/j.virol.2012.09.044. PMC 3523278. PMID 23217617.

ncbi.nlm.nih.gov

Webster DP, Klenerman P, Dusheiko GM (March 2015). "Hepatitis C". Lancet. 385 (9973): 1124–35. doi:10.1016/S0140-6736(14)62401-6. PMC 4878852. PMID 25687730.
Zelenev A, Li J, Mazhnaya A, Basu S, Altice FL (February 2018). "Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study". The Lancet. Infectious Diseases. 18 (2): 215–224. doi:10.1016/S1473-3099(17)30676-X. PMC 5860640. PMID 29153265.
Rao A, Rule JA, Cerro-Chiang G, Stravitz RT, McGuire BM, Lee G, et al. (January 2023). "Role of Hepatitis C Infection in Acute Liver Injury/Acute Liver Failure in North America". Digestive Diseases and Sciences. 68 (1): 304–311. doi:10.1007/s10620-022-07524-6. PMC 9094131. PMID 35546205.
El-Zayadi AR (July 2008). "Hepatic steatosis: a benign disease or a silent killer". World Journal of Gastroenterology. 14 (26): 4120–6. doi:10.3748/wjg.14.4120. PMC 2725370. PMID 18636654.
Alter MJ (May 2007). "Epidemiology of hepatitis C virus infection". World Journal of Gastroenterology. 13 (17): 2436–41. doi:10.3748/wjg.v13.i17.2436. PMC 4146761. PMID 17552026.
Mueller S, Millonig G, Seitz HK (July 2009). "Alcoholic liver disease and hepatitis C: a frequently underestimated combination". World Journal of Gastroenterology. 15 (28): 3462–71. doi:10.3748/wjg.15.3462. PMC 2715970. PMID 19630099.
Zaltron S, Spinetti A, Biasi L, Baiguera C, Castelli F (2012). "Chronic HCV infection: epidemiological and clinical relevance". BMC Infectious Diseases. 12 (Suppl 2): S2. doi:10.1186/1471-2334-12-S2-S2. PMC 3495628. PMID 23173556.
Ko HM, Hernandez-Prera JC, Zhu H, Dikman SH, Sidhu HK, Ward SC, Thung SN (2012). "Morphologic features of extrahepatic manifestations of hepatitis C virus infection". Clinical & Developmental Immunology. 2012: 740138. doi:10.1155/2012/740138. PMC 3420144. PMID 22919404.
Moretti R, Giuffrè M, Merli N, Caruso P, Di Bella S, Tiribelli C, Crocè LS (November 2021). "Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders". Brain Sciences. 11 (12): 1569. doi:10.3390/brainsci11121569. PMC 8699483. PMID 34942871.
Monaco S, Ferrari S, Gajofatto A, Zanusso G, Mariotto S (2012). "HCV-related nervous system disorders". Clinical & Developmental Immunology. 2012: 236148. doi:10.1155/2012/236148. PMC 3414089. PMID 22899946.
Xu JH, Fu JJ, Wang XL, Zhu JY, Ye XH, Chen SD (July 2013). "Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies". World Journal of Gastroenterology. 19 (26): 4234–41. doi:10.3748/wjg.v19.i26.4234. PMC 3710428. PMID 23864789.
Carreño V (November 2006). "Occult hepatitis C virus infection: a new form of hepatitis C". World Journal of Gastroenterology. 12 (43): 6922–5. doi:10.3748/wjg.12.6922. PMC 4087333. PMID 17109511.
Carreño V, Bartolomé J, Castillo I, Quiroga JA (June 2012). "New perspectives in occult hepatitis C virus infection". World Journal of Gastroenterology. 18 (23): 2887–94. doi:10.3748/wjg.v18.i23.2887. PMC 3380315. PMID 22736911.
Robinson JL (July 2008). "Vertical transmission of the hepatitis C virus: Current knowledge and issues". Paediatrics & Child Health. 13 (6): 529–541. doi:10.1093/pch/13.6.529. PMC 2532905. PMID 19436425.
Zignego AL, Giannini C, Gragnani L, Piluso A, Fognani E (August 2012). "Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact". Journal of Translational Medicine. 10 (1): 158. doi:10.1186/1479-5876-10-158. PMC 3441205. PMID 22863056.
Hagan LM, Schinazi RF (February 2013). "Best strategies for global HCV eradication". Liver International. 33 (s1): 68–79. doi:10.1111/liv.12063. PMC 4110680. PMID 23286849.
Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L (August 2011). "Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews". Lancet. 378 (9791): 571–83. doi:10.1016/S0140-6736(11)61097-0. PMC 3285467. PMID 21802134.
Wong T, Lee SS (February 2006). "Hepatitis C: a review for primary care physicians". CMAJ. 174 (5): 649–59. doi:10.1503/cmaj.1030034. PMC 1389829. PMID 16505462.
Patel K, Muir AJ, McHutchison JG (April 2006). "Diagnosis and treatment of chronic hepatitis C infection". BMJ. 332 (7548): 1013–7. doi:10.1136/bmj.332.7548.1013. PMC 1450048. PMID 16644828.
Shah H, Bilodeau M, Burak KW, Cooper C, Klein M, Ramji A, et al. (June 2018). "The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver". CMAJ. 190 (22): E677–E687. doi:10.1503/cmaj.170453. PMC 5988519. PMID 29866893.
Hagan H, Pouget ER, Des Jarlais DC (July 2011). "A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs". The Journal of Infectious Diseases. 204 (1): 74–83. doi:10.1093/infdis/jir196. PMC 3105033. PMID 21628661.
Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, et al. (September 2017). "Direct-acting antivirals for chronic hepatitis C". The Cochrane Database of Systematic Reviews. 2017 (9): CD012143. doi:10.1002/14651858.CD012143.pub3. PMC 6484376. PMID 28922704.
Liang TJ, Ghany MG (May 2013). "Current and future therapies for hepatitis C virus infection". The New England Journal of Medicine. 368 (20): 1907–17. doi:10.1056/NEJMra1213651. PMC 3893124. PMID 23675659.
Ciria R, Pleguezuelo M, Khorsandi SE, Davila D, Suddle A, Vilca-Melendez H, et al. (May 2013). "Strategies to reduce hepatitis C virus recurrence after liver transplantation". World Journal of Hepatology. 5 (5): 237–50. doi:10.4254/wjh.v5.i5.237. PMC 3664282. PMID 23717735.
Gurusamy KS, Tsochatzis E, Toon CD, Xirouchakis E, Burroughs AK, Davidson BR (December 2013). "Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus". The Cochrane Database of Systematic Reviews. 2014 (12): CD006803. doi:10.1002/14651858.CD006803.pub4. PMC 8930021. PMID 24307460.
Rambaldi A, Jacobs BP, Gluud C (October 2007). "Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases". The Cochrane Database of Systematic Reviews. 2009 (4): CD003620. doi:10.1002/14651858.CD003620.pub3. PMC 8724782. PMID 17943794.
Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, et al. (July 2005). "Production of infectious hepatitis C virus in tissue culture from a cloned viral genome". Nature Medicine. 11 (7): 791–796. doi:10.1038/nm1268. PMC 2918402. PMID 15951748.
Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, et al. (September 2017). "Direct-acting antivirals for chronic hepatitis C". The Cochrane Database of Systematic Reviews. 2017 (9): CD012143. doi:10.1002/14651858.CD012143.pub3. PMC 6484376. PMID 28922704.
Abdelwahab KS, Ahmed Said ZN (January 2016). "Status of hepatitis C virus vaccination: Recent update". World Journal of Gastroenterology. 22 (2): 862–73. doi:10.3748/wjg.v22.i2.862. PMC 4716084. PMID 26811632.
Gurusamy KS, Tsochatzis E, Toon CD, Davidson BR, Burroughs AK (December 2013). "Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation". The Cochrane Database of Systematic Reviews. 2013 (12): CD006573. doi:10.1002/14651858.CD006573.pub3. PMC 6599865. PMID 24297303.
Sandmann L, Ploss A (January 2013). "Barriers of hepatitis C virus interspecies transmission". Virology. 435 (1): 70–80. doi:10.1016/j.virol.2012.09.044. PMC 3523278. PMID 23217617.

niddk.nih.gov

"Viral Hepatitis: A through E and Beyond". National Institute of Diabetes and Digestive and Kidney Diseases. April 2012. Archived from the original on 2 February 2016. Retrieved 4 February 2016.

nccam.nih.gov

Hepatitis C and CAM: What the Science Says Archived 2011-03-20 at the Wayback Machine. National Center for Complementary and Alternative Medicine (NCCAM). March 2011. (Retrieved 7 March 2011)

nytimes.com

"Hepatitis Death Rate Creeps past AIDS". New York Times. 27 February 2012. Archived from the original on 30 June 2017. Retrieved 28 July 2013.
McNeil D (December 15, 2015). "Curing Hepatitis C, in an Experiment the Size of Egypt". The New York Times.

oregon.gov

"Hepatitis C Investigative guidelines" (PDF). Oregon Health Authority. January 2020.

phac-aspc.gc.ca

"Hepatitis C Prevention, Support and Research ProgramHealth Canada". Public Health Agency of Canada. Nov 2003. Archived from the original on 22 March 2011. Retrieved 10 January 2012.

pharmaceutical-journal.com

Burns C (17 May 2018). "More than half of patients using needle exchange pilot tested positive for Hepatitis C". The Pharmaceutical Journal.

prepispoison.com

Barnum A (May 12, 1992). "US Biotech is Thriving in Japan: Chiron got its start by using blood test on Emperor Hirohito" (PDF). San Francisco Chronicle.
Barnum A (May 12, 1992). "US Biotech is Thriving in Japan: Chiron got its start by using blood test on Emperor Hirohito" (PDF). San Francisco Chronicle.

psu.edu

citeseerx.ist.psu.edu

Lodi G, Porter SR, Scully C (July 1998). "Hepatitis C virus infection: Review and implications for the dentist". Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 86 (1): 8–22. CiteSeerX 10.1.1.852.7880. doi:10.1016/S1079-2104(98)90143-3. PMID 9690239.
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (April 1989). "Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome" (PDF). Science. 244 (4902): 359–62. Bibcode:1989Sci...244..359C. CiteSeerX 10.1.1.469.3592. doi:10.1126/science.2523562. PMID 2523562.
Fischler B (June 2007). "Hepatitis C virus infection". Seminars in Fetal & Neonatal Medicine. 12 (3): 168–73. CiteSeerX 10.1.1.852.7880. doi:10.1016/j.siny.2007.01.008. PMID 17320495.

qmul.ac.uk

qmro.qmul.ac.uk

Feld JJ, Jacobson IM, Hézode C, Asselah T, Ruane PJ, Gruener N, et al. (December 2015). "Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection". The New England Journal of Medicine. 373 (27): 2599–607. doi:10.1056/NEJMoa1512610. hdl:10722/226358. PMID 26571066.

semanticscholar.org

api.semanticscholar.org

Rosen HR (June 2011). "Clinical practice. Chronic hepatitis C infection". The New England Journal of Medicine. 364 (25): 2429–38. doi:10.1056/NEJMcp1006613. PMID 21696309. S2CID 19755395.
Kim A (September 2016). "Hepatitis C Virus". Annals of Internal Medicine (Review). 165 (5): ITC33–ITC48. doi:10.7326/AITC201609060. PMID 27595226. S2CID 95756.
Ozaras R, Tahan V (April 2009). "Acute hepatitis C: prevention and treatment". Expert Review of Anti-Infective Therapy. 7 (3): 351–61. doi:10.1586/eri.09.8. PMID 19344247. S2CID 25574917.
Dammacco F, Sansonno D (September 2013). "Therapy for hepatitis C virus-related cryoglobulinemic vasculitis". The New England Journal of Medicine. 369 (11): 1035–45. doi:10.1056/NEJMra1208642. PMID 24024840. S2CID 205116488.
Dammacco F, Sansonno D, Piccoli C, Racanelli V, D'Amore FP, Lauletta G (2000). "The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy". Seminars in Liver Disease. 20 (2): 143–57. doi:10.1055/s-2000-9613. PMID 10946420. S2CID 260318352.
Lee MR, Shumack S (November 2005). "Prurigo nodularis: a review". The Australasian Journal of Dermatology. 46 (4): 211–18, quiz 219–20. doi:10.1111/j.1440-0960.2005.00187.x. PMID 16197418. S2CID 30087432.
Sugden PB, Cameron B, Bull R, White PA, Lloyd AR (September 2012). "Occult infection with hepatitis C virus: friend or foe?". Immunology and Cell Biology. 90 (8): 763–73. doi:10.1038/icb.2012.20. PMID 22546735. S2CID 23845868.
Pham TN, Coffin CS, Michalak TI (April 2010). "Occult hepatitis C virus infection: what does it mean?". Liver International. 30 (4): 502–11. doi:10.1111/j.1478-3231.2009.02193.x. PMID 20070513. S2CID 205651069.
Carreño V, Bartolomé J, Castillo I, Quiroga JA (May–June 2008). "Occult hepatitis B virus and hepatitis C virus infections". Reviews in Medical Virology. 18 (3): 139–57. doi:10.1002/rmv.569. PMID 18265423. S2CID 12331754.
Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M (February 2012). "An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region". Liver International. 32 (2): 339–45. doi:10.1111/j.1478-3231.2011.02684.x. PMID 22142261. S2CID 23271017.
Pondé RA (February 2011). "Hidden hazards of HCV transmission". Medical Microbiology and Immunology. 200 (1): 7–11. doi:10.1007/s00430-010-0159-9. PMID 20461405. S2CID 664199.
Imperial JC (June 2010). "Chronic hepatitis C in the state prison system: insights into the problems and possible solutions". Expert Review of Gastroenterology & Hepatology. 4 (3): 355–64. doi:10.1586/egh.10.26. PMID 20528122. S2CID 7931472.
Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, Monarca R (April 2008). "Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis". Journal of Epidemiology and Community Health. 62 (4): 305–13. doi:10.1136/jech.2006.051599. PMID 18339822. S2CID 206989111.
Moyer VA (September 2013). "Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement". Annals of Internal Medicine. 159 (5): 349–57. doi:10.7326/0003-4819-159-5-201309030-00672. PMID 23798026. S2CID 8563203.
Lock G, Dirscherl M, Obermeier F, Gelbmann CM, Hellerbrand C, Knöll A, et al. (September 2006). "Hepatitis C - contamination of toothbrushes: myth or reality?". Journal of Viral Hepatitis. 13 (9): 571–3. doi:10.1111/j.1365-2893.2006.00735.x. PMID 16907842. S2CID 24264376.
Tohme RA, Holmberg SD (October 2010). "Is sexual contact a major mode of hepatitis C virus transmission?". Hepatology. 52 (4): 1497–505. doi:10.1002/hep.23808. PMID 20635398. S2CID 5592006.
Shivkumar S, Peeling R, Jafari Y, Joseph L, Pant Pai N (October 2012). "Accuracy of rapid and point-of-care screening tests for hepatitis C: a systematic review and meta-analysis". Annals of Internal Medicine. 157 (8): 558–66. doi:10.7326/0003-4819-157-8-201210160-00006. PMID 23070489. S2CID 5650682.
Senadhi V (July 2011). "A paradigm shift in the outpatient approach to liver function tests". Southern Medical Journal. 104 (7): 521–5. doi:10.1097/SMJ.0b013e31821e8ff5. PMID 21886053. S2CID 26462106.
Coilly A, Roche B, Samuel D (February 2013). "Current management and perspectives for HCV recurrence after liver transplantation". Liver International. 33 (Suppl 1): 56–62. doi:10.1111/liv.12062. PMID 23286847. S2CID 23601091.
Liu J, Manheimer E, Tsutani K, Gluud C (March 2003). "Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials". The American Journal of Gastroenterology. 98 (3): 538–44. doi:10.1111/j.1572-0241.2003.07298.x. PMID 12650784. S2CID 20014583.
Morgan RL, Baack B, Smith BD, Yartel A, Pitasi M, Falck-Ytter Y (March 2013). "Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies". Annals of Internal Medicine. 158 (5 Pt 1): 329–37. doi:10.7326/0003-4819-158-5-201303050-00005. PMID 23460056. S2CID 15553488.
Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST (April 2013). "Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence". Hepatology. 57 (4): 1333–42. doi:10.1002/hep.26141. PMID 23172780. S2CID 16265266.
Yu ML, Chuang WL (March 2009). "Treatment of chronic hepatitis C in Asia: when East meets West". Journal of Gastroenterology and Hepatology. 24 (3): 336–45. doi:10.1111/j.1440-1746.2009.05789.x. PMID 19335784. S2CID 27333980.
Koretz RL, Lin KW, Ioannidis JP, Lenzer J (January 2015). "Is widespread screening for hepatitis C justified?". BMJ. 350: g7809. doi:10.1136/bmj.g7809. PMID 25587052. S2CID 36816304.
Ledford H (19 October 2020). "The unsung heroes of the Nobel-winning hepatitis C discovery". Nature. 586 (7830): 485. Bibcode:2020Natur.586..485L. doi:10.1038/d41586-020-02932-y. PMID 33082542. S2CID 224822368. Retrieved 20 October 2020.
Wong JB (2006). "Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies". PharmacoEconomics. 24 (7): 661–72. doi:10.2165/00019053-200624070-00005. PMID 16802842. S2CID 6713508.
El Khoury AC, Klimack WK, Wallace C, Razavi H (March 2012). "Economic burden of hepatitis C-associated diseases in the United States". Journal of Viral Hepatitis. 19 (3): 153–60. doi:10.1111/j.1365-2893.2011.01563.x. PMID 22329369. S2CID 27409621.
Arshad M, El-Kamary SS, Jhaveri R (April 2011). "Hepatitis C virus infection during pregnancy and the newborn period--are they opportunities for treatment?". Journal of Viral Hepatitis. 18 (4): 229–36. doi:10.1111/j.1365-2893.2010.01413.x. PMID 21392169. S2CID 35515919.
Hunt CM, Carson KL, Sharara AI (May 1997). "Hepatitis C in pregnancy". Obstetrics and Gynecology. 89 (5 Pt 2): 883–90. doi:10.1016/S0029-7844(97)81434-2. PMID 9166361. S2CID 23182340.
Indolfi G, Resti M (May 2009). "Perinatal transmission of hepatitis C virus infection". Journal of Medical Virology. 81 (5): 836–43. doi:10.1002/jmv.21437. PMID 19319981. S2CID 21207996.
Einav S, Koziel MJ (June 2002). "Immunopathogenesis of hepatitis C virus in the immunosuppressed host". Transplant Infectious Disease. 4 (2): 85–92. doi:10.1034/j.1399-3062.2002.t01-2-02001.x. PMID 12220245. S2CID 27843061.

semanticscholar.org

Moyer VA (September 2013). "Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement". Annals of Internal Medicine. 159 (5): 349–57. doi:10.7326/0003-4819-159-5-201309030-00672. PMID 23798026. S2CID 8563203.

uspreventiveservicestaskforce.org

"Final Update Summary: Hepatitis C: Screening". US Preventive Services Task Force. Retrieved 11 January 2020.

va.gov

hepatitis.va.gov

"Hepatitis C Group Education Class". United States Department of Veteran Affairs. Archived from the original on 2011-11-09. Retrieved 2011-11-20.

washington.edu

courses.washington.edu

Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (April 1989). "Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome" (PDF). Science. 244 (4902): 359–62. Bibcode:1989Sci...244..359C. CiteSeerX 10.1.1.469.3592. doi:10.1126/science.2523562. PMID 2523562.

washingtonpost.com

"Spanish Anesthetist Infected Patients". The Washington Post. Associated Press. 15 May 2007. Archived from the original on 22 August 2016.

web.archive.org

"Hepatitis C Fact sheet". WHO. 24 June 2022. Archived from the original on 31 January 2016. Updated as required.
"Viral Hepatitis: A through E and Beyond". National Institute of Diabetes and Digestive and Kidney Diseases. April 2012. Archived from the original on 2 February 2016. Retrieved 4 February 2016.
Shors T (2011). Understanding viruses (2nd ed.). Burlington, MA: Jones & Bartlett Learning. p. 535. ISBN 978-0-7637-8553-6. Archived from the original on 2016-05-15.
Chronic Hepatitis C Virus Advances in Treatment, Promise for the Future. Springer Verlag. 2011. p. 14. ISBN 978-1-4614-1191-8. Archived from the original on 2016-06-17.
Wilkins T, Malcolm JK, Raina D, Schade RR (June 2010). "Hepatitis C: diagnosis and treatment" (PDF). American Family Physician. 81 (11): 1351–1357. PMID 20521755. Archived (PDF) from the original on 2013-05-21.
Pockros P (2011). Novel and Combination Therapies for Hepatitis C Virus, An Issue of Clinics in Liver Disease. Elsevier Health Sciences. p. 47. ISBN 978-1-4557-7198-1. Archived from the original on 2016-05-21.
"Hepatitis C" (PDF). Centers for Disease Control and Prevention (CDC). Archived (PDF) from the original on 5 January 2012. Retrieved 2 January 2012.
Cramer L (1 September 2011). "Fomites, fomites, fomites!". Microblogology. Archived from the original on 23 September 2020. Retrieved 8 March 2019.
"Hepatitis C FAQs for Health Professionals". Centers for Disease Control and Prevention (CDC). Archived from the original on 4 January 2012. Retrieved 2 January 2012.
Day RA, Paul P, Williams B (2009). Brunner & Suddarth's textbook of Canadian medical-surgical nursing (Canadian 2nd ed.). Philadelphia, PA: Lippincott Williams & Wilkins. p. 1237. ISBN 978-0-7817-9989-8. Archived from the original on 2016-04-25.
Lam NC, Gotsch PB, Langan RC (November 2010). "Caring for pregnant women and newborns with hepatitis B or C" (PDF). American Family Physician. 82 (10): 1225–9. PMID 21121533. Archived (PDF) from the original on 2013-05-21.
"Hepatitis C Group Education Class". United States Department of Veteran Affairs. Archived from the original on 2011-11-09. Retrieved 2011-11-20.
"People Born 1945–1965 (Baby Boomers) – Populations and Settings – Division of Viral Hepatitis". U.S. Centers for Disease Control and Prevention (CDC). 26 July 2019. Archived from the original on 22 October 2019. Retrieved 11 January 2020.
"HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C" (PDF). 12 April 2017. Archived from the original (PDF) on 2017-07-10. Retrieved 28 July 2017.
"FDA approves Vosevi for Hepatitis C". U.S. Food and Drug Administration (FDA) (Press release). 18 July 2017. Archived from the original on 23 July 2017. Retrieved 27 July 2017.
Sanders M (2011). Mosby's Paramedic Textbook. Jones & Bartlett Publishers. p. 839. ISBN 978-0-323-07275-5. Archived from the original on 2016-05-11.
Hepatitis C and CAM: What the Science Says Archived 2011-03-20 at the Wayback Machine. National Center for Complementary and Alternative Medicine (NCCAM). March 2011. (Retrieved 7 March 2011)
Helms RA, Quan DJ, eds. (2006). Textbook of Therapeutics: Drug and Disease Management (8th ed.). Philadelphia, PA [u.a.]: Lippincott Williams & Wilkins. p. 1340. ISBN 978-0-7817-5734-8. Archived from the original on 5 December 2015. Retrieved 7 November 2014.
"U.S. 2014 Surveillance Data for Viral Hepatitis, Statistics & Surveillance, Division of Viral Hepatitis". CDC. Archived from the original on 2016-08-08. Retrieved 2016-08-04.
Table 4.5. "Number and rate of deaths with hepatitis C listed as a cause of death, by demographic characteristic and year – United States, 2004–2008". Viral Hepatitis on the CDC web site. Centers for Disease Control and Prevention, Atlanta, GA. Archived from the original on 9 March 2014. Retrieved 28 July 2013.{{cite web}}: CS1 maint: numeric names: authors list (link)
"Hepatitis Death Rate Creeps past AIDS". New York Times. 27 February 2012. Archived from the original on 30 June 2017. Retrieved 28 July 2013.
"Hepatitis C Kills More Americans than Any Other Infectious Disease". Centers for Disease Control and Prevention. May 4, 2016. Archived from the original on 9 August 2016. Retrieved 3 August 2016.
Blatt LM, Tong M (2004). Colacino JM, Heinz BA (eds.). Hepatitis prevention and treatment. Basel: Birkhäuser. p. 32. ISBN 978-3-7643-5956-0. Archived from the original on 2016-06-24.
"Hepatitis C". World Health Organization (WHO). June 2011. Archived from the original on 2011-07-12. Retrieved 2011-07-13.
Wilken (20 February 1998). "United States Court of Appeals for the Federal Circuit". United States Court of Appeals for the Federal Circuit. Archived from the original on 19 November 2009.
Eurosurveillance editorial team (July 2011). "World Hepatitis Day 2011" (PDF). Euro Surveillance. 16 (30). PMID 21813077. Archived (PDF) from the original on 2011-11-25.
"Hepatitis C Prevention, Support and Research ProgramHealth Canada". Public Health Agency of Canada. Nov 2003. Archived from the original on 22 March 2011. Retrieved 10 January 2012.
Thomas H, Lemon S, Zuckerman A, eds. (2008). Viral Hepatitis (3rd ed.). Oxford: John Wiley & Sons. p. 532. ISBN 978-1-4051-4388-2. Archived from the original on 2016-06-17.
Blackledge C (19 March 2015). "Commissioning supplement: Health inequalities tell a tale of data neglect". Health Service Journal. Archived from the original on 28 July 2015.
"Spanish Anesthetist Infected Patients". The Washington Post. Associated Press. 15 May 2007. Archived from the original on 22 August 2016.
"Spanish Hep C anaesthetist jailed". BBC. 15 May 2007. Archived from the original on 23 October 2007.

who.int

"Hepatitis C Fact sheet". WHO. 24 June 2022. Archived from the original on 31 January 2016. Updated as required.
"Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021". www.who.int. Retrieved 2022-01-19.
"Hepatitis C". World Health Organization (WHO). June 2011. Archived from the original on 2011-07-12. Retrieved 2011-07-13.

emro.who.int

"Egypt becomes the first country to achieve WHO validation on the path to elimination of hepatitis C".